6:10 PM
 | 
Jan 07, 2013
 |  BC Extra  |  Financial News

Hatteras closes fourth fund with boost from government

Hatteras Venture Partners closed its Hatteras Venture Partners IV fund at $125 million, which will invest in seed and early stage companies focused on biopharmaceuticals, medical devices and diagnostics and healthcare IT. Clay Thorp, a general partner at Hatteras, told BioCentury that the firm raised $88 million in private funding...

Read the full 229 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >